earnings-preview — Telefónica (TEF.MC) — Q1 2026
As of 2026-05-06 (8 days ahead of print)
Telefónica Q1 2026 — earnings preview (v2)
Reports: Wednesday 14 May 2026, before market open (verified) Conference call: typically 14:00 CET (10:00 BST) on the day Stance into print: HOLD, balanced setup — first Transform & Grow execution check
Strategic context
This is the first quarterly print under the Transform & Grow plan announced 4 November 2025. The market will scrutinise three things:
- Is Spain operationally delivering on the "best KPIs since 2018" trajectory established at FY25 results?
- Is capex tracking toward the ~12% / sales target for 2026?
- Is the FCF run-rate consistent with the €3.0bn 2026 guidance?
Q4 2025 ran at €9,174M revenue (+1.3%) and €3,198M adjusted EBITDA (+2.8%). Q1 2026 needs to be in a similar zone for the +1.5-2.5% group guidance to look comfortable.
Consensus expectations (consensus pull approximate)
| Metric | Q1 2026 consensus (est.) | Q1 2025 actual | YoY (constant) |
|---|---|---|---|
| Revenue (€m) | ~8,900 | ~8,800 | flat to +1% |
| Adjusted EBITDA (€m) | ~3,000 | ~2,950 | +1.5–2% |
| OIBDA margin | ~33.7% | ~33.5% | +20bps |
| Capex / sales | ~12% | ~12.5% | -50bps |
| FCF (€m) | ~700 | ~600 | growing |
Note: "Q1 2025 actual" is approximated from full-year disclosure and quarterly slides; not all line items are publicly disclosed at the quarterly cadence. Consensus pull is approximate; a production preview would refresh from Bloomberg/FactSet 24–48h before publication.
Top 5 things to watch
1. Spain mobile ARPU sequential — most important
The "best KPIs since 2018" claim from FY25 needs to extend into Q1 2026. Sequential ARPU stable-to-growing = thesis Pillar 1 confirmed. Any sequential deterioration = a leg of the thesis weakens. CNMC monthly portability reports for Jan–Mar 2026 will give an advance read by the time of the call.
2. Capex / sales pacing
Full-year 2026 guidance is ~12% / sales. Q1 historically runs slightly above the full-year run-rate (back-loaded fibre & spectrum in H2). If Q1 2026 shows capex/sales >13%, the FCF guidance becomes harder to defend.
3. FCF run-rate vs €3.0bn 2026 guidance
Each quarter should approximate ~€750m FCF on a smoothed basis. Q1 typically lighter (working capital seasonality). A Q1 FCF print of ~€500-700m keeps the 2026 guidance alive; below €400m and the Street will start questioning the €3bn target.
4. VMO2 / UK strategic commentary
VMO2 lock-up expires June 2026. This Q1 call is the last formal opportunity for Murtra to set expectations before the constraint lifts. Any update on third-party investor interest (STC mentioned in press) materially affects the SOTP component of valuation.
5. Mexico exit final closing details
Sold to Melisa Acquisition (announced Q1 2026 per TelcoTitans). Closing mechanics, proceeds amount, deconsolidation timing all matter for the Hispam segment line in 2026 actuals.
Bull / base / bear scenarios
Bull (~25% probability)
- Spain ARPU +1% sequential
- Q1 FCF €700m+, full-year guidance reaffirmed or upgraded
- VMO2 strategic clarity (third-party investor pipeline named)
- STC engagement signal (board representation request, partnership intent)
Stock reaction: +5–8%, multiple re-rates toward 5.0x EV/EBITDA
Base (~55% probability)
- Spain ARPU stable-to-modestly positive
- Q1 FCF in line, full-year guidance reaffirmed
- VMO2 commentary "ongoing", no specific update
- STC quiet
Stock reaction: -2% to +2%, multiple stable around 4.5x
Bear (~20% probability)
- Spain ARPU sequential decline
- Q1 capex elevated, FCF light
- Guidance not reaffirmed (any caveats)
Stock reaction: -5–8%, multiple compresses toward 4.0x
Trade construction
- Holding through print — thesis is HOLD/+8%, balanced setup. No need to size up or trim ahead of binary event.
- Pair watch — DTE prints same week; relative performance tells you whether sector or stock-specific moves the price.
- Listen for VMO2 specifics — the most asymmetric upside catalyst in the calendar.
Recent estimate revisions (illustrative)
| Date | Source | Action | Note |
|---|---|---|---|
| Apr 2026 | Goldman | Maintain Buy €4.50 | T&G execution pacing |
| Apr 2026 | Berenberg | Maintain Hold €3.50 | Balanced |
| Mar 2026 | New Street | Maintain Reduce €2.60 | Multiple compression risk |
Median PT: €3.90 | Range: €2.60 – €5.00 | Consensus: Neutral (3B/14H/6S)
What changed v1 → v2
| Element | v1 | v2 |
|---|---|---|
| Reporting date | "Thursday 8 May 2026" | Wednesday 14 May 2026 (verified) |
| Strategic context | "Pillar 1 of bull thesis being tested" | "First Transform & Grow execution check; FY25 set 'best KPIs since 2018' bar" |
| Consensus tone | "Median Buy" | Neutral with 14 Holds (verified MarketBeat) |
| Bull case multiple | "EV/EBITDA re-rates toward 4.5x" | "5.0x" (since 4.5x is roughly current) |
| Dividend guard | Implicit (€0.30 maintained) | Removed — dividend already cut for 2026; capital allocation reset is the point |
| Watch items | 5 listed; #5 was STC engagement | 5 listed; #4 is now VMO2 lock-up expiry timing |
Caveat
A real earnings preview pulls live consensus from Bloomberg/FactSet 24–48 hours before publication. The exact Q1 2026 consensus figures here are approximations — a production version would refresh on the day before print. Verified items (reporting date 14 May, sell-side ratings 3B/14H/6S, FY25A baseline figures) are anchored to the v2 facts pack.